Trends Endocrinol Metab (2002) 13:849
We are forced to irrigate the gardens through waste water. Community organization is now more important than ever on the South Coast, essential for defending such a precious resource as water and, with it, the life of families and nature
Nat Rev Neurol 18:724
Oral GLP-1 Formulations and Future Projections Several companies are developing oral GLP-1 formulations, including Novo Nordisk, Pfizer, and smaller firms, positioning them as potential acquisition targets
Both glucagon-like peptide-1 receptor agonist therapy and bariatric surgery reduced the risk [for] weight-related cancer as compared [with] no intervention, Cindy Hsin-Ti Lin, MD, an internal medicine resident at Case Western Reserve University, said during a presentation
Retatrutide (LY3437943) simultaneously activates GLP-1, GIP, and glucagon receptors, making it pharmacologically distinct from semaglutide or tirzepatide